| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
195,811,000 |
| Market
Cap: |
1.32(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.08 - $6.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
155,000 |
191,958 |
| Total Buy Value |
$0 |
$0 |
$579,644 |
$685,344 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
1,500,000 |
1,500,000 |
4,083,538 |
4,083,538 |
| Total Sell Value |
$9,143,159 |
$9,143,159 |
$19,811,348 |
$19,811,348 |
| Total People Sold |
1 |
1 |
4 |
4 |
| Total Sell Transactions |
5 |
5 |
11 |
11 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lenz Brian |
EVP, CFO |
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$30,000 |
D/D |
30,000 |
1,065,501 |
0.01 |
38% |
|
| Kwon Young |
|
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$100,000 |
D/D |
100,000 |
200,000 |
0.01 |
38% |
|
| Grossman Jerrold B |
|
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$100,000 |
D/D |
100,000 |
260,864 |
0.01 |
38% |
|
| Kwon Young |
|
– • – |
2021-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
46% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-09-30 |
4 |
S |
$1.12 |
$153,994 |
I/I |
(137,495) |
13,262,375 |
|
-50% |
|
| Grossman Adam S |
President and CEO |
• • – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650,000 |
2,037,616 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
900,000 |
1,035,501 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-09-29 |
4 |
S |
$1.16 |
$95,706 |
I/I |
(82,505) |
13,399,870 |
|
-48% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-09-28 |
4 |
S |
$1.22 |
$49,536 |
I/I |
(40,603) |
13,482,375 |
|
-34% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-09-27 |
4 |
S |
$1.23 |
$307,500 |
I/I |
(250,000) |
13,522,978 |
|
-37% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-09-24 |
4 |
S |
$1.26 |
$315,000 |
I/I |
(250,000) |
13,772,978 |
|
-28% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-09-23 |
4 |
S |
$1.27 |
$990,600 |
I/I |
(780,000) |
14,022,978 |
|
-20% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-08-19 |
4 |
S |
$1.24 |
$434,436 |
I/I |
(350,352) |
14,802,978 |
|
-7% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-08-18 |
4 |
S |
$1.29 |
$712,570 |
I/I |
(552,380) |
15,153,330 |
|
-2% |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-08-17 |
4 |
S |
$1.35 |
$1,186,774 |
I/I |
(879,092) |
15,705,710 |
|
10% |
|
| Mond James |
EVP, CSO and CMO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
64,361 |
137,535 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
63,936 |
140,078 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
221,447 |
397,545 |
|
- |
|
| Demski Martha J |
Director |
– • – |
2020-09-11 |
4 |
B |
$2.29 |
$5,038 |
I/I |
2,200 |
4,200 |
2.1 |
10% |
|
| Grossman Jerrold B |
Director |
– • – |
2020-09-10 |
4 |
B |
$2.22 |
$11,100 |
D/D |
5,000 |
160,864 |
2.39 |
7% |
|
| Mond James |
EVP, CSO and CMO |
• – – |
2020-09-08 |
4 |
B |
$2.20 |
$8,800 |
D/D |
4,000 |
73,174 |
2.74 |
4% |
|
| Grossman Adam S |
President and CEO |
• • – |
2020-09-08 |
4 |
B |
$2.24 |
$8,960 |
D/D |
4,000 |
176,098 |
2.81 |
4% |
|
| Grossman Jerrold B |
Director |
– • – |
2020-08-21 |
4 |
B |
$2.56 |
$13,586 |
D/D |
5,300 |
155,864 |
2.39 |
-15% |
|
| Demski Martha J |
Director |
– • – |
2020-08-13 |
4 |
B |
$2.88 |
$5,760 |
I/I |
2,000 |
2,000 |
2.1 |
-29% |
|
| Grossman Jerrold B |
Director |
– • – |
2020-08-12 |
4 |
B |
$2.87 |
$29,499 |
D/D |
10,200 |
150,564 |
2.39 |
-25% |
|
222 Records found
|
|
Page 4 of 9 |
|
|
0.07 (1.05%) 
